Exenatide (exendin-4) clinical trials: 194 trials
Page 4 of 4
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
NCT00085969 · Phase 2 · Completed
Linked paper with results
- Trial of Exenatide for Parkinson's Disease
NCT01971242 · Phase 2 · Completed
Linked paper with results
- Exenatide and Metformin Therapy in Overweight Women With PCOS
NCT00344851 · Phase 2 · Completed
Linked paper with results
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
NCT00099333 · Phase 2 · Completed
Linked paper with results
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
NCT00064714 · Phase 2 · Completed
Linked paper with results
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
NCT00103935 · Phase 2 · Completed
Linked paper with results
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
NCT01174810 · Phase 2 · Status unknown
Linked paper with results
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
NCT00254254 · Phase 2 · Completed
Linked paper with results
- Pharmacology of Exenatide in Pediatric Sepsis
NCT01573806 · Phase 1/2 · Withdrawn
Linked paper with results
- A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
NCT01297062 · Phase 1 · Completed
Posted results
- Pharmacogenomics of GLP1 Receptor Agonists
NCT05762744 · Phase 1 · Terminated
Posted results
- Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
NCT01798264 · Phase 1 · Completed
Posted results
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
NCT01664624 · Phase 1 · Completed
Posted results
- A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
NCT00782418 · Phase 1 · Completed
Posted results
- Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
NCT03167411 · Phase 1 · Completed
Posted results
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
NCT03645408 · Phase 1 · Terminated
Posted results
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
NCT02690987 · Early phase 1 · Status unknown
Linked paper with results
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
NCT00971659 · Phase 1 · Completed
Linked paper with results
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
NCT02059564 · Phase 1 · Status unknown
Linked paper with results
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
NCT00254800 · Phase 1 · Completed
Linked paper with results
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
NCT00612794 · Phase 1 · Completed
Linked paper with results
- A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
NCT01077323 · Phase not stated · Completed
Posted results
- Comparison of Type 2 Diabetes Pharmacotherapy Regimens
NCT05073692 · Phase not stated · Completed
Posted results
- CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
NCT00635492 · Phase not stated · Completed
Posted results
- Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
NCT01060059 · Phase not stated · Completed
Posted results
- Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
NCT01147627 · Not applicable · Completed
Posted results
- Effects of Obesity Treatments on Food Preferences and Metabolism
NCT01724060 · Phase not stated · Completed
Posted results
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
NCT02962492 · Not applicable · Completed
Posted results
- Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
NCT01089569 · Not applicable · Completed
Posted results
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
NCT00775684 · Not applicable · Completed
Posted results
- Evaluation of Exenatide in Patients With Diabetic Neuropathy
NCT00855439 · Not applicable · Completed
Posted results
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
NCT01364584 · Not applicable · Completed
Posted results
- Impact of Exenatide on Sleep in Type 2 Diabetes
NCT01136798 · Not applicable · Completed
Posted results
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
NCT01444898 · Not applicable · Completed
Posted results
- GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
NCT02673931 · Not applicable · Status unknown
Linked paper with results
- Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
NCT07309094 · Phase not stated · Recruiting
Linked paper with results
- GLP-1 Analogs for Neuroprotection After Cardiac Arrest
NCT02442791 · Not applicable · Completed
Linked paper with results
- The Microvascular Function of GLP-1 and Its Analogues
NCT01677104 · Not applicable · Completed
Linked paper with results
- Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
NCT04909333 · Not applicable · Completed
Linked paper with results
- The Differential Effects of Diabetes Therapy on Inflammation
NCT02150707 · Phase not stated · Completed
Linked paper with results
- Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
NCT01056549 · Not applicable · Completed
Linked paper with results
- Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
NCT01687582 · Not applicable · Completed
Linked paper with results
- Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
NCT01046721 · Not applicable · Completed
Linked paper with results
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
NCT02244164 · Not applicable · Terminated
Linked paper with results